Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Investor profile

Cormorant Asset Management

Venture Capital · Founded 2013 · Boston, United States

Website ↗LinkedIn ↗Crunchbase ↗Dealroom ↗

Its services to pooled investment vehicles

164 portfolio companies Venture Capital · $19B invested · 248 investments · Investor rank #127 · Last investment 7/2026
Portfolio companies ↑ 33% 5y
164
Decacorns
4
Thoroughbreds ↑ 6% 5y
18
Exits

Cormorant Asset Management’s biggest exits.

Portfolio companies that IPO’d or were acquired at $1B+, with the valuation recorded at exit and — for those still public — their value today. Exit events come from each company’s funding-round history; entry stage from Cormorant Asset Management’s transaction record.

BridgeBio
$2.0B IPO · 2019
Entered Series B+Now $17BHealth
Innovent Biologics
$2.0B IPO · 2018
Entered Series B+Now $17BHealth
MyoKardia
IPO · 2015
Entered Series ANow $13BHealth
Avidity Biosciences
IPO · 2020
Entered Series B+Now $12BHealth
Praxis Precision Medicines
$698M IPO · 2020
Entered Series B+Now $8.0BHealth
Spyre Therapeutics | Aeglea BioTherapeutics
$130M IPO · 2016
Now $7.7BHealth
Erasca
$300M IPO · 2021
Entered Series ANow $6.5BHealth
Centessa Pharmaceuticals
$1.9B IPO · 2021
Entered Series ANow $6.1BHealth
Twist Bioscience
$372M IPO · 2018
Entered Series B+Now $5.8BHealth
Apellis Pharmaceuticals
$691M IPO · 2017
Entered Series B+Now $5.3BHealth
Ambrx
$4.7B IPO · 2021
Entered Series B+Now $1.6BHealth
Parabilis Medicines
$2.4B IPO · 2026
Entered Series B+Now $4.2BHealth
Portfolio analysis

Where Cormorant Asset Management's portfolio is concentrated.

Distribution of portfolio companies by headquarters country, sector, entry stage and current growth stage. Across all 164 portfolio companies. "Stage entered" is the first priced round the investor joined, derived from the investor’s transaction history.

By countryCount
  1. USA145
  2. China7
  3. Denmark2
  4. Ireland2
  5. Switzerland2
  6. UK2
  7. Belgium1
  8. Canada1
  9. Germany1
  10. Netherlands1
By sectorCount
  1. Health161
  2. Food3
  3. Chemicals1
  4. Jobs Recruitment1
  5. Media1
  6. Robotics1
By stage enteredCount
  1. Series B+114
  2. Series A40
  3. Seed2
By growth stageCount
  1. Late Growth137
  2. Breakout Stage26
  3. Early Growth1
Portfolio market map

Inside Cormorant Asset Management's portfolio.

The 60 highest-funded portfolio companies, of 164 tracked.

Freenome
Health · Unicorn
$1.1B
Zai Lab
Health · Unicorn
$1.8B
Parabilis Medicines
Health · Unicorn
$4.2B
BridgeBio
Health · Decacorn
$17B
Innovent Biologics
Health · Decacorn
$17B
Tessera Therapeutics
Health · Unicorn
$1.5B
Avidity Biosciences
Health · Decacorn
$12B
Alumis
Health · Unicorn
$3.2B
Solid Biosciences
Health
$498M
Neurogene
Health
$460M
Olema Oncology
Health
$500M
Galecto | Damora Therapeutics
Health · Unicorn
$2.1B
RayzeBio
Health · Unicorn
$3.7B
Constellation Pharmaceuticals
Health · Unicorn
$1.7B
Korro Bio
Health
$106M
Greenlight Biosciences
Health
$46M
Ventus Therapeutics
Health
$280M
Verve Therapeutics
Health
$566M
Umoja Biopharma
Health · Unicorn
$1.1B
Everest Medicines
Health
$798M
Terremoto Biosciences
Health
$875M
Tyra Biosciences
Health · Unicorn
$1.5B
Affinivax
Health · Unicorn
$2.1B
Tango Therapeutics
Health · Unicorn
$4.3B
Ambrx
Health · Unicorn
$1.6B
Aspen Neuroscience
Health
$738M
Erasca
Health · Unicorn
$6.5B
Pyxis Oncology
Health
$127M
Crystalys Therapeutics
Health · Unicorn
$1.0B
Adarx Pharmaceuticals
Health
$800M
Agomab
Health
$466M
Viela Bio
Health · Unicorn
$3.0B
Neurona Therapeutics
Health
$600M
Star Therapeutics
Health
$500M
Talaris Therapeutics
Health
Gelesis
Health
$54M
Orchard Therapeutics
Health
$303M
Harpoon Therapeutics
Health
$475M
GondolaBio
Health · Unicorn
$1.2B
BioAge Labs
Health
$680M
Triveni Bio
Health
$575M
Latigo Biotherapeutics
Health
$600M
JenaValve Technology
Health
$400M
Electra Therapeutics
Health
$732M
Fore Biotherapeutics
Health
$270M
NiKang Therapeutics
Health
$382M
Ventyx Biosciences
Health
$822M
AltruBio
Health
$900M
Chroma Medicine
Health
$540M
Elpiscience Biopharmaceuticals
Health
$420M
Ensoma
Health
$425M
Attovia
Health
$525M
Rapport Therapeutics
Health · Unicorn
$1.6B
Centessa Pharmaceuticals
Health · Unicorn
$6.1B
Twist Bioscience
Health · Unicorn
$5.8B
Supira Medical
Health
$480M
Moma Therapeutics
Health
$600M
Spyre Therapeutics | Aeglea BioTherapeutics
Health · Unicorn
$7.7B
Bigfoot Biomedical
Health
$114M
Moximed
Health
$244M
Portfolio founders

Where Cormorant Asset Management's portfolio founders come from.

136 founders across the 100 highest-funded portfolio companies — by current location, university attended, and the companies they worked at before founding. Sourced from the founder records the API links to each portfolio company.

LocationCount
  1. United States109
  2. Belgium4
  3. China4
  4. Switzerland4
  5. United Kingdom4
  6. Denmark3
  7. Cuba1
  8. France1
  9. Israel1
  10. Netherlands1
UniversityCount
  1. Massachusetts Institute of Technology16
  2. Stanford University8
  3. Harvard University7
  4. University of California, Berkeley7
  5. Harvard Medical School5
  6. University of California, San Diego5
  7. The Ohio State University4
  8. University College London4
  9. University of Pennsylvania4
  10. Imperial College London3
Previous companyCount
  1. Harvard Medical School5
  2. Novartis5
  3. Estring4
  4. Genentech4
  5. Pfizer4
  6. Broad Institute3
  7. Dana-Farber Cancer Institute3
  8. Hd Administration3
  9. Incyte3
  10. Lucentis3
How Cormorant Asset Management stacks up

Similar investors.

Peers the API surfaces as most similar by portfolio shape, with Dealroom investor rank and portfolio scale.

Fidelity Investments
Venture Capital · Boston
#7 rank 362 companies $6.2T portfolio
Novo Holdings
Venture Capital · Gentofte Municipality
#138 rank 197 companies $135B portfolio
SOSV
Venture Capital · Princeton
#963 rank 1,251 companies $41B portfolio
OrbiMed
Private Equity · New York City
#70 rank 393 companies $451B portfolio
Khosla Ventures
Venture Capital · Menlo Park
#53 rank 852 companies $1.9T portfolio
ARCH Venture Partners
Venture Capital · Chicago
#67 rank 251 companies $513B portfolio
NEA
Venture Capital · Menlo Park
#36 rank 1,184 companies $2.5T portfolio
RA Capital Management
Venture Capital · Boston
#71 rank 314 companies $367B portfolio
Every figure on this page is sourced live from the Dealroom next-gen API. Sections v1 shows that the API does not yet expose — shareholding-based holdings, Power-Law rankings & vintage time-series, entity-filtered news, and market sentiment — are omitted here rather than sourced elsewhere.